Internal Medicine • Research • Visualized VISUALIZED: Evaluating Secondary T-Cell Malignancies as Adverse Reactions to CAR T-Cell Therapy 1 min read Read further: Evaluating Secondary T-Cell Malignancies as Adverse Reactions to CAR T-Cell Therapy FacebookXPinterestLinkedIn
Article NL V.36 (2025) • Internal Medicine • Research Evolocumab Reduces Coronary Plaque Inflammation and... 3 min read
Article NL V.36 (2025) • Internal Medicine • Research Probiotics as a Potential Intervention for Alzheimer’s... 3 min read
Article NL V.36 (2025) • Internal Medicine • Practice Plant-Based Diet Reduces Body Weight and HbA1c in Type... 3 min read
Article NL V.36 (2025) • Internal Medicine • Practice Regional Differences in Burnout Among U.S. Internal... 3 min read